Correction to: ACMT Position Statement: Addressing the Rising Cost of Prescription Antidotes

  • Maryann Mazer-Amirshahi
  • Andrew Stolbach
  • Lewis S. Nelson
Correction
  • 17 Downloads

Correction to: Journal of Medical Toxicology

  https://doi.org/10.1007/s13181-017-0639-z

This article contains a couple typographical errors in the table and in the formatting of references. The authors and the journal apologize for those errors and respectfully include a corrected table and corrected reference list here.

Table 1

Average Wholesale Price of Selected Antidotes 2012, 2016, 2017

Antidote

Formulation

Quantity

AWP 2012

AWP 2016

AWP 2017

Acetylcysteine injection (Acetadote®)

200 mg/mL 30 mL

4

$994.38

$994.38

$1034.94 (2016) Per unit: $258.74

scorpion (centruroides) immune F(ab’)2 injection (Anascorp®)

1 vial

1

$4375.00

$4905.68

$5150.96

antivenin (crotalidae polyvalent immune Fab (Crofab®)

1 gram vial

2

$5121.60

$6169.20

$6632.40 (2016) Per unit: $3316.20

Deferoxamine (Fresenius)

2 gram vial

1

$49.44

$49.44

$49.44 (2009)

Deferoxamine (Hospira)

2 gram vial

4

$176.40

$151.58

$151.58 (2016) Per unit: $37.90

Fomepizole (Bioniche - now part of Mylan)

1 g/mL 1.5 mL

1

$870.00

$1132.50

$1132.50 (2015)

Fomepizole (Sandoz)

1 g/mL 1.5 mL

1

$1,364.85

$1,364.85

$1,364.85

Fomepizole (X-gen Pharmaceuticals)

1 g/mL 1.5 mL

1

$1290.00

$1290.00

$1290.00

Glucarpidase (Voraxaze®)

1000 Units/vial

1

$27,000.00

$31,254.00

$34,456.80

Hydroxocobalamin (Cyanokit)

5 gram

1

$750.75

$750.75

$821.32

Leucovorin (Blue Point Laboratories and Sagent)

200 mg vial powder

1

$48.00

$48.00

$48.00 (2016)

Levoleucovorin (Fusilev®)

50 mg vial powder

1

$240.00

$273.60

$246.00

Naloxone (Hospira)

0.4 mg/mL

10

$45.00

$185.28

185.28 (2014) Per unit: $18.53

Phytonadione (Hospira)

10 mg/mL

25

$404.60

$1,133.10

$1322.40 Per unit: $52.90

Phytonadione (Hospira)

1 mg/0.5 mL

25

$172.20

$127.50

$127.50 Per unit: $10.20

Phytonadione (International Medication System)

1 mg/0.5 mL

10

$51.00 in 2013

$216.00

$216.00 (2015) Per unit: $43.20

Succimer (Chemet®)

100 mg capsules

100 caps

$860.10

$1,700.04

$1785.05 Per unit: $17.85

Uridine Triacetate (Vistogard®)

10 g/packet

20

N/A

$90,000.00

$96,312.00 Per unit: $4,815.60

Vitamin K (Mephyton®)

5 mg oral tab

100

$1283.00 in 2013

$7,051.21

$7.051.21 (2015) Per unit: $70.51

References

  1. 1.
    Dart RC, Goldfrank LR, Chyka PA, Lotzer D, Woolf AD, McNally J, Snodgrass WR, Olson KR, Scharman E, Geller RJ, Spyker D, Kraft M, Lipsy R. Combined evidence-based literature analysis and consensus guidelines for stocking of emergency antidotes in the United States. Ann Emerg Med 2000; 36: 126-132.Google Scholar
  2. 2.
    Kesselheim AS, Avorn Sarpatwari A. The high cost of prescription drugs in the United States: origins and prospects for reform. JAMA 2016;318:858-71.Google Scholar
  3. 3.
    FDA. Frequently asked questions about patents and exclusivity. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/ucm079031.htm. Accessed October 21, 2016.
  4. 4.
    Kesselheim AS. Using market exclusivity incentives to promote pharmaceutical innovation. N Eng J Med 2010;363:1855-62.Google Scholar
  5. 5.
    Divino V, DeKoven M, Kleinrock M. Orphan drug expenditures in the United States: a historical and prospective analysis, 2007-18. Health Aff 2016;35:1588-94.Google Scholar
  6. 6.
    Tufts Center for the Study of Drug Development. Costs to develop and win marketing approval for a new drug is $2.6 billion. http://csdd.tufts.edu/news/complete_story/pr_tufts_csdd_2014_cost_study. Accessed October 21, 2016.
  7. 7.
    Kantarjian H, Rajkumar SV. Why are cancer drugs so expensive in the United States and what are the solutions? Mayo Clin Proc 2015;90:500-4.Google Scholar
  8. 8.
    Reference for prices of new drugs are higher in the US Hirschler B. Exclusive—transatlantic divide: how US pays three times more for drugs. Reuters. http://www.reuters.com/article/us-pharmaceuticals-usa-comparison-idUSKCN0S61KU20151012. Published October 12, 2015. Accessed July 26, 2017.
  9. 9.
    Kanavos P, Ferraio A, Vandoros S, Anderson GF. Higher U.S. branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs. Heath Aff 201;32:753-61.Google Scholar
  10. 10.
    National Institute for Health Care and Excellence (NICE). https://www.nice.org.uk. Accessed October 26, 2016.
  11. 11.
    Qualifying for pediatric exclusivity under Section 505A of the Federal Food, Drug, and Cosmetic Act: frequently asked questions on pediatric exclusivity (505A), The Pediatric "Rule," and their interaction. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/ucm077915.htm. Accessed October 21, 2016.
  12. 12.
    BTG settles CroFab patent litigation with Bioclon and RDT. https://www.thepharmaletter.com/article/btg-settles-crofab-patent-litigation-with-bioclon-and-rdt. Accessed August 26, 2017.
  13. 13.
    Uhl K, Peters JR, Flanagan K. High-cost generic drugs-implications for patients and policymakers. N Engl J Med 2015;372:685-6.Google Scholar
  14. 14.
    O’Brien E. Why drug prices remain insanely high and 6 things you can do to save. http://www.marketwatch.com/story/six-tips-for-fighting-rising-prescription-drug-costs-2015-09-15. Accessed July 26, 2017
  15. 15.
    Red Book Online® [database online]. Greenwood Village, Colorado: Thomson Reuters (Healthcare) Inc. Updated periodically. Accessed January 23, 2016.Google Scholar
  16. 16.
    Heindel GA, Trella JD, Osterhoudt KC. Rising cost of antidotes in the US: cost comparison from 2010 to 2015. Clin Toxicol 2017; 55: 360-363.Google Scholar
  17. 17.
    NPR. Price soars for key weapon against heroin overdoses. http://www.npr.org/sections/health-shots/2015/09/10/439219409/naloxone-price-soars-key-weapon-against-heroin-overdoses. Accessed October 21, 2016.
  18. 18.
    STAT. Doctors have toxic reaction to Valent pricing for a lead poisoning drug. https://www.statnews.com/pharmalot/2016/10/11/valeant-drug-prices-lead-poisoning/. Accessed October 21, 2016.
  19. 19.
    The Washington Post. This $153,000 rattlesnake bite is everything wrong with American healthcare. https://www.washingtonpost.com/news/wonk/wp/2015/07/20/this-153000-rattlesnake-bite-is-everything-wrong-with-american-health-care/. Accessed October 26, 2016.
  20. 20.
    Red Book Online® [database online]. Greenwood Village, Colorado: Thomson Reuters (Healthcare) Inc. Updated periodically. Accessed November 15, 2012.Google Scholar
  21. 21.
    Red Book Online® [database online]. Greenwood Village, Colorado: Thomson Reuters (Healthcare) Inc. Updated periodically. Accessed March 8, 2016.Google Scholar
  22. 22.
    Red Book Online® [database online]. Greenwood Village, Colorado: Thomson Reuters (Healthcare) Inc. Updated periodically. Accessed June 20, 2017.Google Scholar

Copyright information

© American College of Medical Toxicology 2018

Authors and Affiliations

  • Maryann Mazer-Amirshahi
    • 1
  • Andrew Stolbach
    • 2
  • Lewis S. Nelson
    • 3
  1. 1.Medstar Washington Hospital CenterGeorgetown University School of MedicineWashingtonUSA
  2. 2.School of MedicineJohns Hopkins UniversityBaltimoreUSA
  3. 3.Department of Emergency MedicineRutgers New Jersey Medical SchoolNewarkUSA

Personalised recommendations